[go: up one dir, main page]

MX2011013385A - Metodos para cultivar celulas madre y celulas progenitoras. - Google Patents

Metodos para cultivar celulas madre y celulas progenitoras.

Info

Publication number
MX2011013385A
MX2011013385A MX2011013385A MX2011013385A MX2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A MX 2011013385 A MX2011013385 A MX 2011013385A
Authority
MX
Mexico
Prior art keywords
methods
progenitor cells
cells
culturing stem
stem
Prior art date
Application number
MX2011013385A
Other languages
English (en)
Inventor
Cynthia Bamdam
Original Assignee
Minerva Biotechnologies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Minerva Biotechnologies Corp filed Critical Minerva Biotechnologies Corp
Publication of MX2011013385A publication Critical patent/MX2011013385A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0607—Non-embryonic pluripotent stem cells, e.g. MASC
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G01N33/57492—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites involving compounds localized on the membrane of tumor or cancer cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N11/00—Carrier-bound or immobilised enzymes; Carrier-bound or immobilised microbial cells; Preparation thereof
    • C12N11/16—Enzymes or microbial cells immobilised on or in a biological cell
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0634—Cells from the blood or the immune system
    • C12N5/0647—Haematopoietic stem cells; Uncommitted or multipotent progenitors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0693—Tumour cells; Cancer cells
    • C12N5/0695—Stem cells; Progenitor cells; Precursor cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/998—Proteins not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2502/00—Coculture with; Conditioned medium produced by
    • C12N2502/30—Coculture with; Conditioned medium produced by tumour cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Developmental Biology & Embryology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)

Abstract

La presente solicitud describe un método para cultivar, expandir o desarrollar células madre o tipo madre o células madre pluripotentes inducidas sobre una superficie, que incluye adherir las células a la superficie a través de un ligando que se une a la superficie y las células.
MX2011013385A 2009-06-11 2010-06-11 Metodos para cultivar celulas madre y celulas progenitoras. MX2011013385A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US18631009P 2009-06-11 2009-06-11
US32377910P 2010-04-13 2010-04-13
PCT/US2010/038438 WO2010144887A1 (en) 2009-06-11 2010-06-11 Methods for culturing stem and progenitor cells

Publications (1)

Publication Number Publication Date
MX2011013385A true MX2011013385A (es) 2012-05-29

Family

ID=43306642

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2011013385A MX2011013385A (es) 2009-06-11 2010-06-11 Metodos para cultivar celulas madre y celulas progenitoras.

Country Status (15)

Country Link
US (4) US8535944B2 (es)
EP (3) EP4043552A1 (es)
JP (1) JP2012529890A (es)
KR (4) KR20210019599A (es)
CN (2) CN102549146B (es)
AU (2) AU2010259858A1 (es)
BR (1) BRPI1011127A2 (es)
CA (1) CA2767164C (es)
DO (1) DOP2011000384A (es)
EA (1) EA026732B1 (es)
IL (1) IL216902B (es)
MX (1) MX2011013385A (es)
MY (1) MY157524A (es)
SG (1) SG176801A1 (es)
WO (1) WO2010144887A1 (es)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004022580A2 (en) 2002-09-09 2004-03-18 Dana-Farber Cancer Institute, Inc. Bh3 peptides and method of use thereof
EP2008106A2 (en) 2006-03-31 2008-12-31 Dana-Farber Cancer Institute Methods of determining cellular chemosensitivity
CN101652469B (zh) * 2006-12-06 2014-04-16 米纳瓦生物技术公司 用于鉴定和操作细胞的方法
JP2012505636A (ja) * 2008-10-09 2012-03-08 ミネルバ バイオテクノロジーズ コーポレーション 細胞において多能性を誘導する方法
DK2499236T3 (da) 2009-11-12 2020-03-23 Technion Res & Dev Foundation Dyrkningsmedier, cellekulturer og metoder til dyrkning af pluripotente stamceller i en udifferentieret tilstand
IL281453B (en) 2009-11-17 2022-07-01 Astellas Inst For Regenerative Medicine Methods for preparing human rpe cells and pharmaceutical preparations of human rpe cells
EP2582399A4 (en) * 2010-06-16 2015-04-15 Minerva Biotechnologies Corp NEW PROGRAMMING OF CANCER CELLS
CA2830503A1 (en) 2011-03-17 2012-09-20 Minerva Biotechnologies Corporation Method for making pluripotent stem cells
CA2835453A1 (en) * 2011-05-09 2012-11-15 Minerva Biotechnologies Corporation Genetically engineered growth factor variants
EP2707381B1 (en) * 2011-05-11 2019-08-14 Exosome Diagnostics, Inc. Nucleic acid extraction from heterogeneous biological materials
CA2852244C (en) * 2011-10-17 2023-10-17 Minerva Biotechnologies Corporation Media for stem cell proliferation and induction
AU2013289913A1 (en) * 2012-07-13 2015-03-05 Minerva Biotechnologies Corporation Method for inducing cells to less mature state
JP6546087B2 (ja) * 2012-07-24 2019-07-17 ミネルバ バイオテクノロジーズ コーポレーション Ｎｍｅバリアント種の発現および抑制
CN108175856B (zh) * 2012-08-14 2024-01-26 米纳瓦生物技术公司 干细胞增强疗法
CA2885230C (en) 2012-09-19 2021-08-03 Anthony Letai Dynamic bh3 profiling
KR20140073215A (ko) * 2012-12-06 2014-06-16 삼성전자주식회사 세포 분리용 조성물, 키트 및 이를 이용한 세포 분리 방법
IL240695B2 (en) * 2013-02-20 2024-03-01 Minerva Biotechnologies Corp Nme inhibitors and methods of using nme inhibitors
WO2015035996A1 (en) * 2013-09-11 2015-03-19 Amphidex A/S Cell culture products for adherent cell cultures and manufacture thereof
JP6663852B2 (ja) 2013-09-19 2020-03-13 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Ｂｈ３プロファイリングの方法
SG11201608389RA (en) 2014-04-07 2016-11-29 Minerva Biotechnologies Corp Anti-nme antibody
US10596492B2 (en) 2014-07-09 2020-03-24 Sudhin Biopharma Particle settling devices
US11746159B2 (en) 2015-02-10 2023-09-05 Minerva Biotechnologies Corporation Humanized anti-MUC1* antibodies
CN104630144B (zh) * 2015-02-13 2018-02-13 中国医科大学 一种脐血间充质干细胞的分离及培养方法
WO2016176299A1 (en) * 2015-04-27 2016-11-03 Dana-Farber Cancer Institute, Inc. Compositions and methods for assessing toxicity using dynamic bh3 profiling
CA3035168A1 (en) * 2015-08-28 2017-03-09 Keith D. Crawford Adult stem cell compositions and methods of identification and isolation
EP3394106A1 (en) * 2015-12-22 2018-10-31 Abbvie Stemcentrx LLC Novel anti-mmp16 antibodies and methods of use
EP3652315A4 (en) 2017-07-12 2021-09-01 Exosome Diagnostics, Inc. METHODS FOR ISOLATION AND ENRICHMENT OF EXTRACELLULAR VESICLE POPULATIONS DERIVED FROM BIOFLUIDS, AND ASSOCIATED METHODS OF USE
CN112020385B (zh) 2018-04-18 2023-01-06 苏德新生物制药公司 颗粒沉降装置
CA3128384A1 (en) 2019-02-04 2020-08-13 Minerva Biotechnologies Corporation Anti-nme antibody and method of treating cancer or cancer metastasis
US11679345B2 (en) 2020-03-19 2023-06-20 Sudhin Biopharma Particle settling devices
CA3181655A1 (en) 2020-06-08 2021-12-16 Minerva Biotechnologies Corporation Anti-nme antibody and method of treating cancer or cancer metastasis
US20230242678A1 (en) 2020-06-26 2023-08-03 Minerva Biotechnologies Corporation Anti-nme antibody and method of treating cancer or cancer metastasis
IL316221A (en) 2022-04-12 2024-12-01 Minerva Biotechnologies Corp Anti-MUC1* variant antibodies and their uses

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5342790A (en) * 1992-10-30 1994-08-30 Becton Dickinson And Company Apparatus for indirect fluorescent assay of blood samples
GB9413029D0 (en) * 1994-06-29 1994-08-17 Common Services Agency Stem cell immobilisation
ATE345387T1 (de) * 1998-03-18 2006-12-15 Corixa Corp Verbindungen und verfahren für therapie und diagnose von lungenkrebs
AU4328801A (en) * 2000-02-24 2001-09-03 Xcyte Therapies Inc Simultaneous stimulation and concentration of cells
US6797514B2 (en) 2000-02-24 2004-09-28 Xcyte Therapies, Inc. Simultaneous stimulation and concentration of cells
CN1455680A (zh) * 2000-09-11 2003-11-12 达纳-法伯癌症协会有限公司 Muc1胞外域和癌症治疗组合物及方法
CA2430060C (en) 2000-11-27 2015-11-24 Minerva Biotechnologies Corporation Identification and use of cell surface receptor-binding ligands for the diagnosis and treatment of cancer
IL158126A0 (en) * 2001-03-29 2004-03-28 Univ Ramot Peptides and antibodies to muc 1 proteins
KR100450578B1 (ko) 2002-03-05 2004-09-30 주식회사 안지오랩 엔엠23 단백질을 유효성분으로 하는, 매트릭스메탈로프로테아제 활성 억제 및 혈관신생 억제용 조성물
US7141369B2 (en) * 2002-04-25 2006-11-28 Semibio Technology, Inc. Measuring cellular metabolism of immobilized cells
WO2003099708A1 (en) * 2002-05-28 2003-12-04 Matsushita Electric Industrial Co., Ltd. Process for producing nanoparticle and nanoparticle produced by the process
EP1537143A2 (en) 2002-09-05 2005-06-08 Cell Center Cologne GmbH Immunogenic muc1 glycopeptides
US20040067585A1 (en) * 2002-10-07 2004-04-08 Yu-Chi Wang Cell cultivation surface and method of making the same
EP2363410B1 (en) 2002-11-27 2017-10-11 Minerva Biotechnologies Corporation Isoforms of MUC1
US20060173171A1 (en) * 2003-08-26 2006-08-03 Bamdad Cynthia C Techniques and compositions for diagnosis and treatment of cancer (muci)
JP5635726B2 (ja) 2004-09-14 2014-12-03 ミネルバ バイオテクノロジーズ コーポレーション 癌の診断方法及び治療方法
GB0424560D0 (en) * 2004-11-08 2004-12-08 Leuven K U Res & Dev Heart valve tissue engineering
US20060252087A1 (en) * 2005-01-18 2006-11-09 Biocept, Inc. Recovery of rare cells using a microchannel apparatus with patterned posts
JP2008543276A (ja) * 2005-03-30 2008-12-04 ミネルバ バイオテクノロジーズ コーポレーション Ｍｕｃ１発現細胞の増殖
EP2631652A1 (en) 2005-04-05 2013-08-28 Corning Incorporated Label free biosensor
CN101652469B (zh) * 2006-12-06 2014-04-16 米纳瓦生物技术公司 用于鉴定和操作细胞的方法
PE20081760A1 (es) * 2007-02-09 2009-01-01 Genentech Inc Anticuerpos anti-robo4 y sus usos
US20090092603A1 (en) * 2007-09-25 2009-04-09 Bamdad Cynthia C Early diagnosis and treatment of drug resistance in muc1-positive cancer

Also Published As

Publication number Publication date
EP4043552A1 (en) 2022-08-17
US8535944B2 (en) 2013-09-17
IL216902B (en) 2019-11-28
EP3633024A1 (en) 2020-04-08
CA2767164A1 (en) 2010-12-16
CN104293732A (zh) 2015-01-21
AU2016204735B2 (en) 2018-05-17
KR20190122749A (ko) 2019-10-30
US20100316688A1 (en) 2010-12-16
US20250067746A1 (en) 2025-02-27
KR20120025601A (ko) 2012-03-15
US20140044696A1 (en) 2014-02-13
CA2767164C (en) 2019-10-15
US20220252604A1 (en) 2022-08-11
BRPI1011127A2 (pt) 2017-06-06
WO2010144887A1 (en) 2010-12-16
MY157524A (en) 2016-06-15
DOP2011000384A (es) 2012-12-15
EP2440652B1 (en) 2019-11-27
AU2016204735A1 (en) 2016-07-28
EP2440652A4 (en) 2013-05-29
SG176801A1 (en) 2012-01-30
EP2440652A1 (en) 2012-04-18
KR20170075023A (ko) 2017-06-30
EA026732B1 (ru) 2017-05-31
IL216902A0 (en) 2012-02-29
CN102549146A (zh) 2012-07-04
CN102549146B (zh) 2016-01-13
AU2010259858A1 (en) 2012-02-02
KR20210019599A (ko) 2021-02-22
JP2012529890A (ja) 2012-11-29
EA201290003A1 (ru) 2012-09-28

Similar Documents

Publication Publication Date Title
MX2011013385A (es) Metodos para cultivar celulas madre y celulas progenitoras.
IL288185A (en) New methods and mediums for growing pluripotent stem cells
EP2408903A4 (en) PLURIPOTENTE AND MULTIPOTENTE CELL CULTURE ON MICROWAVES
MX356756B (es) Células madre pluripotentes en microportadores.
IL252607A0 (en) Culture media, cell cultures and methods of culturing pluripotent stem cells in an undifferentiated state
MX2013001045A (es) Organoide hepatico, sus usos y metodo de cultivo para obtenerlos.
WO2010129294A3 (en) Small molecules supporting pluripotent cell growth and methods thereof
PH12013500349A1 (en) Differentiation of pluripotent stem cells
MX2010000348A (es) Cultivo de celulas madre pluripotentes individuales.
MX349658B (es) Metodo para la diferenciacion de las celulas madre pluripotentes en celulas de lecho vascular.
MX350311B (es) Anticuerpos anti-phf-tau y sus usos.
EP4585589A3 (en) Stem cell cultures
IL207083A0 (en) Synthetic surfaces for culturing stem cell derived cardiomyocytes
MX342200B (es) Método de tratamiento de células madre mesenquimales y su uso en el tratamiento de enfermedades asociadas a estrés oxidativo.
PH12014500771A1 (en) Enzyme cocktails prepared from mixed cultures
WO2012126013A3 (en) Method for making pluripotent stem cells
IN2012DN00581A (es)
MX349801B (es) Sustratos de enzimas de ácido nucleico.
IN2012DN00852A (es)
ZA201504388B (en) Method for culturing pluripotent stem cells
EP3064576A4 (en) POLYPEPTIDE COMPOSITION AND CULTURING PROCESS FOR PLURIPOTENTE STEM CELLS THEREWITH
IN2014DN10038A (es)
WO2011143400A3 (en) Method and composition for inducing human pluripotent stem cells
ZA201405320B (en) Induced pluripotent stem cells prepared from human kidney-derived cells
WO2010150190A3 (en) Diphasic algal culture system

Legal Events

Date Code Title Description
FG Grant or registration